News

Treatment with the anti-obesity medications can reduce health risks for patients with heart failure by more than 40%. These ...
Two new COVID-19 Omicron sub-variants, Nimbus (NB.1.8.1) and Stratus (XFG), have been detected in India. Dr Neha Rastogi ...
Scientists treated a person’s type 1 diabetes with genetically modified insulin-producing cells that evaded immune system attacks. This is the first therapy for the condition that does not require imm ...
Eli Lilly's new pill shows promise. The drug helped people with diabetes lose weight in trials. The pill, orforglipron, led ...
New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...
People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...
Although this disease has significant incidence and huge social impact, still there is lack of awareness among public regarding this illness. It's important for public to understand options for it's ...
The once-daily pill also helped 75 per cent of patients who received the highest dose of orforglipron lower their A1C level - ...
An oral GLP-1 significantly lowered body weight and HbA1c at 72 weeks for adults with overweight or obesity and type 2 ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Eli Lilly and Company is ...
Can type 2 diabetes be reversed? Dr Swati Goray, Consultant Endocrinology at Jupiter Hospital, Pune, explains how remission ...
In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.